Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia.

ABSTRACT:

SUBMITTER: Peng Y 

PROVIDER: S-EPMC9276344 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature